Nanalysis Scientific (CVE:NSCI) Trading Down 10.3% – Should You Sell?

Shares of Nanalysis Scientific Corp. (CVE:NSCI) were down 10.3% during trading on Thursday . The stock traded as low as C$0.13 and last traded at C$0.13. Approximately 98,931 shares were traded during trading, an increase of 84% from the average daily volume of 53,888 shares. The stock had previously closed at C$0.15.

Nanalysis Scientific Stock Performance

The firm’s 50 day moving average is C$0.15 and its 200 day moving average is C$0.17. The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42. The stock has a market cap of C$13.78 million, a P/E ratio of -1.20 and a beta of -0.60.

Nanalysis Scientific Company Profile

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.